Both in Pharmaceuticals
Jade Biosciences vs Oric Pharmaceuticals
Over the past year JBIO returned +47.1% and ORIC returned −25.6%; their daily moves had a correlation of 0.11.
JBIO +47.1% ORIC −25.6%Growth of $1, one year, split-adjusted
| Metric | JBIO | ORIC |
|---|---|---|
| Price | $13.96 | $9.62 |
| Market cap | $887.8M | $997.1M |
| Today | −1.97% | +7.01% |
| 1 month | +1.4% | −23.2% |
| 6 months | −42.4% | −1.5% |
| Year to date | −9.5% | +17.6% |
| 1 year | +47.1% | −25.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $461.2M | $264.8M |
| Dividend yield | — | — |
| Volatility (60d) | 51.4% | 94.5% |
| Short % of float | 20.7% | 25.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).